Trials / Completed
CompletedNCT01634373
Steady State Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets
An Open-Label, Randomised, 2-Period, 2-Treatment, 2-sequence, Crossover, Steady State Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets [Test Formulation; Torrent Pharmaceuticals Ltd., India] Versus Seroquel® 300 mg Tablet [Reference Formulation; AstraZeneca, USA] in Schizophrenic Patients.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Torrent Pharmaceuticals Limited · Industry
- Sex
- All
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Objective: Primary objective was to study Steady-state bioequivalence of Torrent's Quetiapine Fumarate Tablets 300 mg. Study Design: Randomized, Two-Way, Crossover, multiple Dose, and Open-Label
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Torrent's Quetiapine Fumarate Tablets |
Timeline
- First posted
- 2012-07-06
- Last updated
- 2012-07-06
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT01634373. Inclusion in this directory is not an endorsement.